Peter Beck has a bold plan to turn Rocket Lab into a self-launching tier-1 space power, but reaching the price target that would prove him right requires several high-stakes moves to land perfectly.

Rocket Lab (NASDAQ:RKLB | RKLB Price Prediction) has built a track record of building and flying rockets. Now its founder and CEO, Peter Beck, wants a much bigger role. When he announced the Iridium Communications (NASDAQ:IRDM) acquisition, Beck said the deal sets up Rocket Lab as “a self-launching, tier-1 space power that will deliver critical communications capability to millions of users worldwide.” Iridium stockholders approved the deal in September.

The stock has fallen behind the business. Shares are down 2.22% year to date at $68.21, even though Q2 revenue rose 62% to a record. Several things need to go right for Rocket Lab to reach $125 per share in 2027.

Wall Street Already Sees 56% Upside

The average analyst target is $106.57, which implies 56% upside. Ratings stand at 4 Strong Buy, 12 Buy, 4 Hold and zero Sell. Rocket Lab has exceeded revenue estimates in each of the last 4 quarters. Q2 EPS of -$0.08 missed the -$0.0767 estimate, but that figure included $8.58M in acquisition costs. Backlog reached $2.36B, up 137%, and Q3 revenue guidance is $250M-$265M.

Here’s What It Takes to Reach $125

Rocket Lab isn’t profitable yet, so price-to-sales is the better metric. Shares trade at 56.7x trailing sales. At $125, that multiple would rise to roughly 104x. That’s a big premium, but it is close to the 93x investors pay for SpaceX (NASDAQ:SPCX). SpaceX posted $7.81B in Q2 revenue, and $648M of that came from launch services. Launch alone is a large market.

How Rocket Lab might reach $125.

Neutron’s debut: Neutron is Rocket Lab’s reusable medium-lift rocket, and its starting price of $50 million to $55 million puts it head-to-head with Falcon 9. CNBC reported that management expects boosters to fly 10 to 20 times each. Beck put it bluntly: “Neutron demand is just not a concern.”
Defense spending: The FY2027 budget includes $17.9 billion for Golden Dome. Rocket Lab already holds an $816M Space Development Agency contract and a $397M Flatellite award.
Iridium: Iridium generated more than $870 million in annual revenue, and the deal is expected to close in mid-2027.
Margin gains: Non-GAAP gross margin rose to 41.5% from 36.9%. The adjusted EBITDA loss shrank to $8.8M from $27.6M.

The Neutron launch can change the dynamic and make Rocket Lab a viable challenger to SpaceX. With the cost per launch expected to fall from around $130 million to $50 million as volume ramps higher, it would make Rocket Lab a profitable alternative to its rival.

Key risks: Neutron’s maiden year-end launch window is narrowing, and Rocket Lab raised $1.53B by selling stock in the first half of 2026, which dilutes existing shareholders.

Shares Topped $125 Within the Past Year

Reaching $125 requires an 83% gain. The stock has already traded above that level: its 52-week range runs from $37.57 to $151, a swing of about 302%. With a beta of 2.938, Rocket Lab is likely to move far more than the overall market. Over five years, shares have gained 363.7%.

$125 Is a Stretch, but Within Reach

Hitting $125 would take an 83% gain in 2027. Analysts already see 56% upside, the backlog keeps hitting records, and Neutron could start competing directly with SpaceX. Execution risk is real. Still, returns at this level are unlikely every year, and this is the model for how Rocket Lab could deliver outsized returns in 2027.

Contact [email protected] for any questions or corrections.